Study on Cannabis Edibles Packaging Warnings

This study is looking at how different warning labels on cannabis edibles packaging affect people's understanding of the product. Researchers want to see if a warning about delayed effects, with or without an icon or dosing instructions, helps people understand the risks and safety better. You could be eligible if you are between 18 and 65 years old, live in the United States, and speak English. The study aims to understand how these warnings impact how appealing the product seems, how safe people think it is, and their perceived likelihood of experiencing unwanted effects. The study is currently recruiting 1250 participants, but its overall status is unclear.

Study design
This study involves 1250 participants who will be assigned to view different cannabis edibles packaging. Some will see no warning, while others will see various warning messages, icons, and dosing instructions.
What's involved
Participants will view cannabis edibles packaging and answer a series of questions. This will be measured at Minute 1 for product appeal, perceived safety, and likelihood of unwanted effects.
Compensation
Not stated in the trial record.
Follow-up
Participants' responses regarding product appeal, safety, and perceived likelihood of unwanted effects are measured at Minute 1.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07496489

Perceptions of Proposed Warnings for Cannabis Edibles Packaging

Completed
NAAges 18–65Interventional
Wake Forest University Health Sciences
~1,250 participants
Updated 2026-08-27 on ClinicalTrials.gov
What's tested:No Warning ControlDelayed Effects Text OnlyDelayed Effects Plus IconDelayed Effects Plus DoseDelayed Effects Plus Dose Plus Adverse Effects

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Product appeal score
Measured over Minute 1
+5 more outcomes measured
Cannabis Use
1 sites across 1 states
North Carolina1
  • Beth Reboussin, PhD · PRINCIPAL_INVESTIGATOR · Wake Forest University Health Sciences

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

English-speaking by self-selection
United States resident

Exclusion

Already participated in a precursor project (IRB00104038, IRB000111438)
Eligible but demographic and user group strata have already been met
  • Product appeal scoreMinute 1

    One item to assess the appeal of the product. Results will be reported as means. Question: How appealing is this edible to you? Response options: (0) Not at all appealing to (10) Very appealing. Higher score denoting more appeal

  • Perception of product safety scoreMinute 1

    One item to assess the participants' perception of the safety of the product. Results will be presented as the frequency of each type of response. Question: How safe do you think it would be to eat this edible? Response options: (1) Not at all safe, (2) Slightly safe, (3) Somewhat safe, (4) Moderately safe, (5) Very safe. Higher score denoting more safe to eat

  • Perceived likelihood of experiencing unwanted effects scoreMinute 1

    One item to assess the participants' perception of the likelihood of experiencing unwanted effects. Results will be presented as the frequency of each type of response. Question: How likely are you to experience unwanted effects if you eat this edible? Response options: (1) Not at all likely, (2) Slightly likely, (3) Somewhat likely, (4) Moderately likely, (5) Very likely. Higher score denoting greater likelihood of experiencing side effects

  • Interest in a free sample scoreMinute 1

    One item to assess how interested a participant would be in a free sample of the product. Results will be presented as the frequency of each type of response. Question: How interested would you be in a free sample of this edible? Response options: (1) Not at all interested, (2) Slightly interested, (3) Somewhat interested, (4) Moderately interested, (5) Very interested. Higher score denoting more interest

  • Concern about the risks of overconsumption due to warning scoreMinute 1

    One item to assess how much the warning makes the participant concerned about the risks of overconsumption for participants randomized to view a package with a warning (intervention conditions only). Results will be presented as the frequency of each type of response. Question: How much does this warning make you concerned about potential risks from eating too much of this edible? Response options: (1) Not at all, (2) A little, (3) Somewhat, (4) Quite a bit, (5) A great deal. Higher score denotes more concern

  • Improved understanding of safe consumption due to warning scoreMinute 1

    One item to assess how much the warning gives the participant a better understanding of how to safely consume an edible (intervention conditions only). Results will be presented as the frequency of each type of response. Question: How much does this warning give you a better understanding of how to safely consume this edible? Response options: (1) Not at all, (2) a little, (3) somewhat, (4) quite a bit, (5) a great deal. Higher score denotes better understanding of safety